Luyan Pharma Co Ltd (002788) - Total Liabilities

Latest as of March 2026: CN¥9.95 Billion CNY ≈ $1.46 Billion USD

Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has total liabilities worth CN¥9.95 Billion CNY (≈ $1.46 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Luyan Pharma Co Ltd (002788) investment intensity to see how much of total assets are deployed in long-term investments.

Luyan Pharma Co Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Luyan Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Luyan Pharma Co Ltd asset portfolio.

Luyan Pharma Co Ltd Competitors by Total Liabilities

The table below lists competitors of Luyan Pharma Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Hainan Haiqi Transportation Group Co Ltd
SHG:603069
China CN¥1.80 Billion
DRI Healthcare Trust
TO:DHT-U
Canada $463.66 Million
Zhejiang Noblelift Equip
SHG:603611
China CN¥6.33 Billion
Jiangsu Tongli Risheng Machinery Co. Ltd.
SHG:605286
China CN¥2.63 Billion
Wolong Real Estate Group Co Ltd
SHG:600173
China CN¥4.13 Billion
Blumar
SN:BLUMAR
Chile CL$528.09 Million
BRASKEM PFD ADR/2 O.N.
F:BRD
Germany €98.38 Billion
Sturm Ruger & Company Inc
NYSE:RGR
USA $74.49 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Luyan Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Luyan Pharma Co Ltd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.11 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.95 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.75 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Luyan Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Luyan Pharma Co Ltd (2011–2025)

The table below shows the annual total liabilities of Luyan Pharma Co Ltd from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥10.07 Billion
≈ $1.47 Billion
+6.62%
2024-12-31 CN¥9.45 Billion
≈ $1.38 Billion
+7.15%
2023-12-31 CN¥8.82 Billion
≈ $1.29 Billion
-1.96%
2022-12-31 CN¥8.99 Billion
≈ $1.32 Billion
+21.00%
2021-12-31 CN¥7.43 Billion
≈ $1.09 Billion
+23.29%
2020-12-31 CN¥6.03 Billion
≈ $882.18 Million
+6.70%
2019-12-31 CN¥5.65 Billion
≈ $826.77 Million
+27.92%
2018-12-31 CN¥4.42 Billion
≈ $646.34 Million
+23.86%
2017-12-31 CN¥3.57 Billion
≈ $521.83 Million
+67.16%
2016-12-31 CN¥2.13 Billion
≈ $312.17 Million
-20.49%
2015-12-31 CN¥2.68 Billion
≈ $392.61 Million
+0.69%
2014-12-31 CN¥2.66 Billion
≈ $389.93 Million
+17.50%
2013-12-31 CN¥2.27 Billion
≈ $331.85 Million
+27.67%
2012-12-31 CN¥1.78 Billion
≈ $259.93 Million
+82.53%
2011-12-31 CN¥973.17 Million
≈ $142.40 Million
--

About Luyan Pharma Co Ltd

SHE:002788 China Pharmaceutical Retailers
Market Cap
$593.54 Million
CN¥4.06 Billion CNY
Market Cap Rank
#11380 Global
#3174 in China
Share Price
CN¥10.44
Change (1 day)
-3.78%
52-Week Range
CN¥7.99 - CN¥27.49
All Time High
CN¥22328.40
About

Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products, and prepared slices of traditional Chinese medicine in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail ch… Read more